Skip to main content
Log in

Immunoassay quantification of human insulin added to ternary parenteral nutrition containers: comparison of two methods

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Adding insulin directly into infusion bags seems to be a useful method for controlling hyperglycemia in patients under ternary parenteral nutrition (TPN). Its efficacy is assessed by glycemic monitoring but few data are available on insulin stability in this situation. Among the various methods for quantifying insulin levels in human serum, the immunoassay ones seemed potentially appropriate for a TPN admixture containing high lipid concentrations. We sought to identify and validate which of two immunoassay methods was the better to quantify human insulin and consequently be adapted to studying its stability in a TPN admixture. Two immunoassay methods to quantify recombinant human insulin were assessed in industrial TPN: an immunoradiometric assay (IRMA) and an immunoelectrochemiluminometric assay (IECMA). Validation trials for both methods were based on the accuracy profile method. Interference with immunometric assays due to the high lipidic content of TPN was eliminated through an improved preparation protocol using a bovine serum albumin (BSA) diluted in phosphate buffer saline (PBS). The relative total error of IECMA varied from 1.74 to 4.52% while it varied from −0.32 to 8.37% with IRMA. Only IECMA provided an accuracy profile with a 95% confidence interval of calculated-tolerance limits falling between the chosen acceptance limits (i.e., total error ≤±10%). IECMA combined with a BSA dilution is a simple and semi-automatic method that provides an accurate quantification of human insulin in a TPN admixture without any interference from lipids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors, et al. A.S.P.E.N. Clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013;37:23–36.

    Article  CAS  Google Scholar 

  2. Edakkanambeth Varayil J, Yadav S, Miles JM, Okano A, Kelly DG, Hurt RT, et al. Hyperglycemia during home parenteral nutrition administration in patients without diabetes. JPEN J Parenter Enteral Nutr. 2015.

  3. Olveira G, Tapia MJ, Ocón J, Cabrejas-Gómez C, Ballesteros-Pomar MD, Vidal-Casariego A, et al. Parenteral nutrition-associated hyperglycemia in non-critically ill inpatients increases the risk of in-hospital mortality (multicenter study). Diabetes Care. 2013;36:1061–6.

    Article  CAS  Google Scholar 

  4. Mirtallo J, Canada T, Johnson D, Kumpf V, Petersen C, Sacks G, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:S39–70.

  5. Bassons T, Maria Sanchez J, Bassas L, Cardona D, Ordonez J, Bonal J. Insulina recuperada según los componentes de la nutrición parenteral. Rev SENPE. 1985;4:93–9.

    Google Scholar 

  6. Rusavý Z, Sramek V, Suchat R, Lacigova S, Topolcan O. Effects of carrier solution on insulin bioavailability. JPEN J Parenter Enteral Nutr. 2004;28:439–41.

    Article  Google Scholar 

  7. Yilmaz B, Kadioglu Y, Capoglu I. Determination of insulin in humans with insulin-dependent diabetes mellitus patients by HPLC with diode array detection. J Chromatogr Sci. 2012;50:586–90.

    Article  CAS  Google Scholar 

  8. Hoyer GL, Nolan PE, LeDoux JH, Moore LA. Selective stability-indicating high-performance liquid chromatographic assay for recombinant human regular insulin. J Chromatogr A. 1995;699:383–8.

    Article  CAS  Google Scholar 

  9. Yu K-H, Tsao H-L, Lin S-J, Chen C-Y. Quantitative analysis of insulin in total parenteral nutrition bag in Taiwan. J Food Drug Anal. 2016;24:214–9.

    Article  CAS  Google Scholar 

  10. Oliva A, Fariña J, Llabrés M. Development of two high-performance liquid chromatographic methods for the analysis and characterization of insulin and its degradation products in pharmaceutical preparations. J Chromatogr B Biomed Sci App. 2000;749:25–34.

    Article  CAS  Google Scholar 

  11. Hess C, Thomas A, Thevis M, Stratmann B, Quester W, Tschoepe D, et al. Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2012;404:1813–22.

    Article  CAS  Google Scholar 

  12. Marcuard SP, Dunham B, Hobbs A, Caro JF. Availability of insulin from total parenteral nutrition solutions. JPEN J Parenter Enteral Nutr. 1990;14:262–4.

    Article  CAS  Google Scholar 

  13. Martínez-Subiela S, Cerón JJ. Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays. Can Vet J. 2005;46:625–9.

    Google Scholar 

  14. Owen WE, Roberts WL. Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin Chem. 2004;50:257–9.

    Article  CAS  Google Scholar 

  15. Heurtault B, Reix N, Meyer N, Gasser F, Wendling M-J, Ratomponirina C, et al. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification. Clin Chem Lab Med. 2014;52:355–62.

    Article  CAS  Google Scholar 

  16. Manley SE, Stratton IM, Clark PM, Luzio SD. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem. 2007;53:922–32.

    Article  CAS  Google Scholar 

  17. Agin A, Jeandidier N, Gasser F, Grucker D, Sapin R. Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: bi-insulin IRMA preliminary assessment. Clin Chem Lab Med. 2006;44:1379–82.

    Article  CAS  Google Scholar 

  18. Sapin R, Le Galudec V, Gasser F, Pinget M, Grucker D. Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with insulin lispro. Clin Chem. 2001;47:602–5.

    CAS  Google Scholar 

  19. Cassidy JP, Luzio SD, Marino MT, Baughman RA. Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”? Clin Chem Lab Med. 2012;50:663–6.

    Article  CAS  Google Scholar 

  20. Levy-Marchal C, Bridel MP, Sodoyez-Goffaux F, Koch M, Tichet J, Czernichow P, et al. Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children. Diabetes Care. 1991;14:61–3.

    Article  CAS  Google Scholar 

  21. Hubert P, Nguyen-Huu J-J, Boulanger B, Chapuzet E, Chiap P, Cohen N, et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal—part II. J. Pharm. Biomed. Anal. 2007;45:70–81.

    CAS  Google Scholar 

  22. COFRAC. SH GTA 04 Guide technique d’accréditation de vérification (portée A)/validation (portée B) des méthodes en biologie médicale [Internet]. 2011 [cited 2017 Jan 10]. Available from: https://www.cofrac.fr/documentation/SH-GTA-04.

  23. Kelley M, DeSilva B. Key elements of bioanalytical method validation for macromolecules. AAPS J. 2007;9:E156–63.

    Article  Google Scholar 

  24. Christianson MA, Schwartz MW, Suzuki N. Determinants of insulin availability in parenteral nutrition solutions. JPEN J Parenter Enteral Nutr. 2006;30:6–9.

    Article  CAS  Google Scholar 

  25. Ciszewska M, Knyt A, Kopec B, Pertkiewicz M. Insulin availability from all in one and fat-free nutrients admixtures. Clin Nutr. 1994;13(Supplement 1):56.

    Article  Google Scholar 

  26. Sapin R. Interferences in immunoassays: mechanisms and outcomes in endocrinology. Ann Endocrinol. 2008;69:415–25.

    Article  CAS  Google Scholar 

  27. Ichikawa E, Kimura M, Mori H, Yamazaki F, Hirano K. Apparent increase of insulin peak area in HPLC analysis of a preparation consisting of a mixture of insulin and total parenteral nutrition. Chem Pharm Bull (Tokyo). 2006;54:1196–9.

    Article  CAS  Google Scholar 

  28. Saracevic A, Nikolac N, Simundic A-M. The evaluation and comparison of consecutive high speed centrifugation and LipoClear® reagent for lipemia removal. Clin Biochem. 2014;47:309–14.

    Article  CAS  Google Scholar 

  29. Livesey JH, Donald RA. Prevention of adsorption losses during radioimmunoassay of polypeptide hormones: effectiveness of albumins, gelatin, caseins, Tween 20 and plasma. Clin Chim Acta Int J Clin Chem. 1982;123:193–8.

    Article  CAS  Google Scholar 

  30. Andersen L, Jørgensen PN, Jensen LB, Walsh D. A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies. Clin Biochem. 2000;33:627–33.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Mrs. Alexandra Tavernier, M.A. University of Glasgow, U.K.; Professeur Agrégée, University of Lille, for her extensive revision of the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Damien Lannoy.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Henry, H., Lannoy, D., Simon, N. et al. Immunoassay quantification of human insulin added to ternary parenteral nutrition containers: comparison of two methods. Anal Bioanal Chem 409, 3677–3684 (2017). https://doi.org/10.1007/s00216-017-0311-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-017-0311-0

Keywords

Navigation